[The predictive factors of a good response to the transfusion of erythrocyte concentrates in patients with controlled digestive hemorrhage].
Not all patients respond the same to the transfusion of erythrocyte concentrates (EC) after achieving the control of gastrointestinal bleeding. The aim of the present study was to analyze the predictive factors of good response to EC transfusion in patients with controlled gastrointestinal hemorrhage and determine the stability of transfusion performance. A prospective study was carried out in 61 patients with controlled gastrointestinal bleeding. The epidemiologic data were compared and prior to transfusion different analytical and hemodynamic variables were compared basally. On completion of the transfusion analytical controls were performed at 4 and 24 hours. The response was considered as optimum when pretransfusional basal hemoglobin (Hb) increased at least 1 g and the hematocrit (HCT) rose 3 points for each EC administered. The response to transfusion was optimum in 29 patients and bad in 32. The women responded significantly better than the men (p < 0.05), as did patients with lower weight (p < 0.05) and body surface (p < 0.05). The mean age of the responding patients was greater (p = 0.06) and the height, to the contrary, lower (p = 0.09). No significant differences were observed in the presence or not of associated disease, type of lesion causing the hemorrhage, or number of EC transfused. Likewise, no differences were found with regard to the pretransfusional values of TAM, TAS, FC, PVC, Hb, HCT, VCM, HCM, urea and creatinine. The only variables with independent predictive value of good response were female sex and low body surface. The difference between the Hb and HCT values at 4 and 24 h after transfusion did not achieve statistical significance. 1. The hemodynamic state and the degree of basal anemia do not condition response to EC transfusion in controlled gastrointestinal bleeding. 2. The response to the administration of EC is better in women and subjects of lower body surface. 3. Postransfusional analytical control at 4 hours allows early evaluation of the effects of the transfusion in patients at risk of recurrent hemorrhage.